Design and optimization of the variables in the adsorptive stripping voltammetric determination of rufloxacin in tablets, human plasma and urine
-
Add time:07/26/2019 Source:sciencedirect.com
An adsorptive stripping voltammetric method with a hanging mercury drop electrode was developed for the determination of the fluoroquinolone rufloxacin in tablets, human plasma and urine. Measurements were obtained in differential pulse mode and a multivariate strategy was used to optimize the variables involved. Besides the independent effects of the variables, a strong interaction between scan rate and pulse duration has been found. Rufloxacin was analysed at concentrations between 1.7 × 10−8 and 1.9 × 10−7 M with a detection limit of 9.2 × 10−9 M. Diluted tablet solutions and urine samples were analysed directly, while plasma samples needed an extraction procedure before voltammetric analysis. An improved HPLC procedure was used as comparative method.
We also recommend Trading Suppliers and Manufacturers of Rufloxacin hydrochloride (cas 106017-08-7). Pls Click Website Link as below: cas 106017-08-7 suppliers
Prev:Effects of bio-compatible metal ions on rufloxacin photochemistry, photophysics and photosensitization: Copper(II)
Next:High-performance liquid chromatographic determination of rufloxacin and its main active metabolite in biological fluids) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- High-performance liquid chromatographic determination of rufloxacin and its main active metabolite in biological fluids07/27/2019
- Effects of bio-compatible metal ions on rufloxacin photochemistry, photophysics and photosensitization: Copper(II)07/25/2019
- Fluorimetric assay of rufloxacin in serum and in pharmaceutical formulations07/24/2019
- Simultaneous determination of rufloxacin, fenbufen and felbinac in human plasma using high-performance liquid chromatography07/23/2019
- Photosensitization induced by the antibacterial fluoroquinolone Rufloxacin leads to mutagenesis in yeast07/22/2019
- Optimization and validation of a CZE method for Rufloxacin hydrochloride (cas 106017-08-7) determination in coated tablets07/20/2019
-
Health and Chemical more >


